Boxer Capital, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$13,785,000
-12.7%
250,0000.0%0.48%
-31.4%
Q2 2020$15,783,000
+23.6%
250,0000.0%0.69%
-20.3%
Q1 2020$12,773,000
-35.7%
250,0000.0%0.87%
-22.5%
Q4 2019$19,873,000
+63.8%
250,0000.0%1.12%
+27.9%
Q3 2019$12,130,000
-7.8%
250,0000.0%0.88%
-22.3%
Q2 2019$13,150,000
-0.6%
250,0000.0%1.13%
-26.1%
Q1 2019$13,233,000
-53.9%
250,000
-64.3%
1.53%
-56.9%
Q4 2018$28,735,000700,0003.55%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2019
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders